Endometrioid carcinoma of the ovary: a retrospective study.
Thirty-nine women with endometrioid carcinoma of the ovary were studied for factors relating to their presentation, treatment and survival. Nine of the women (23%) had a concomitant adenocarcinoma of the endometrium at the time of presentation. There were no significant differences in age at presentation or menopausal status between the two groups. The actuarial 5-year survival for women with endometrioid carcinoma of the ovary alone was 43%, 95% confidence interval (CI) 24% to 62% (stage I 80%, CI 45% to 100%, stage II 62%, CI 27% to 97%, and stage III 21%, CI 0% to 42%). The 5-year survival for women with concomitant endometrial tumours was 62.5% (CI 28.5% to 96.5%). The difference in the overall survival rate between the two groups was not significant.
Tidy
J
J
Ludwig Institute for Cancer Research, St Mary's Hospital Medical School, London.
Mason
W P
WP
D000230:Adenocarcinoma; D000328:Adult; D000368:Aged; D004715:Endometriosis; D005260:Female; D006801:Humans; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D010051:Ovarian Neoplasms; D011379:Prognosis; D012189:Retrospective Studies; D014594:Uterine Neoplasms